Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 269, Issue 3, 2012, Pages 1027-1033

  Xiayun, He ^a,b   Ou, Dan ^a,b   Ying, Hongmei ^a,b   Zhu, Guopei ^a,b   Hu, Chaosu ^a,b   Liu, Taifu ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cisplatin; Gemcitabine; Intensity modulated radiation therapy; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY WEIGHT; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CRANIAL NERVE PARALYSIS; DISEASE SEVERITY; DISTANT METASTASIS; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; FIBROSIS; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY DISEASE; LEUKOPENIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NECK FIBROSIS; NECROSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RASH; SIDE EFFECT; TEMPORAL NECROSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; TRISMUS; TUMOR VOLUME; VOMITING; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHINA; CISPLATIN; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RIBONUCLEOTIDE REDUCTASES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84857050277     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1669-9     Document Type: Article

References (26)

1. CY Chen F Han C Zhao, et al. 2009 Treatment results and late complication of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone Br J Radial 82 452 458 10.1259/bjr/72813246 1:STN:280:DC%2BD1Mzltlymsg%3D%3D
2. AW Lee SY Tung DT Chua, et al. 2010 Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 102 1188 1198 20634482 10.1093/jnci/djq258
3. JL Yi L Gao XD Huang, et al. 2006 Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution Int J Radiat Oncol Biol Phys 65 1 161 168 16542792 10.1016/j.ijrobp.2005.12.003
4. SA Yeh Y Tang CC Lui, et al. 2005 Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone Int J Radiat Oncol Biol Phys 62 672 679 15936544 10.1016/j.ijrobp.2004.11.002
5. AW Lee WM Sze JS Au, et al. 2005 Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 1107 1116 15752890 10.1016/j.ijrobp.2004.07.702
6. M Al-Sarraf M LeBlanc PG Giri, et al. 1998 Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 1310 1317 9552031 1:STN:280:DyaK1c3htFOmtQ%3D%3D
7. AW Lee WH Lau SY Tung, et al. 2005 Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group J Clin Oncol 23 6966 6975 16192584 10.1200/JCO.2004.00.7542 1:CAS:528:DC%2BD2MXhtFCrsbjP
8. JC Lin JS Jan CY Hsu, et al. 2003 Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 631 637 12586799 10.1200/JCO.2003.06.158
9. AT Chan PM Teo RK Ngan, et al. 2002 Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma; progression-free survival analysis of a phase III randomized trial J Clin Oncol 20 2038 2044 11956263 10.1200/JCO.2002.08.149 1:CAS:528: DC%2BD38XjvVKmsrs%3D
10. IW Tham SW Hee RM Yeo, et al. 2009 Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre Singapore experience Int J Radiat Oncol Biol Phys 75 1481 1486 19386431 10.1016/j.ijrobp.2009.01.018
11. S Lin JJ Lu L Han, et al. 2010 Sequential chemotherapy and intensity modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases BMC Cancer 10 39 20146823 10.1186/1471-2407-10-39
12. N Lee J Harris AS Garden, et al. 2009 Intensity-modulated radiotherapy therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225 J Clin Oncol 27 3684 3690 19564532 10.1200/JCO.2008.19.9109
13. L Han SJ Lin JJ Pan, et al. 2010 Prognostic factor of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy Chin J Cancer 29 153 158
14. J Wang J Li X Hong, et al. 2008 Retrospective case series of gemcitabine and cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma Oral Oncol 44 464 470 17826303 10.1016/j.oraloncology.2007.06.004
15. RK Ngan HH Yiu WH Lau, et al. 2002 Combination gemcitabine plus cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study Ann Oncol 13 1252 1258 12181249 10.1093/annonc/mdf200 1:STN:280:DC%2BD38visVeqtw%3D%3D
16. DT Chua JS Sham GK Au 2005 Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma Am J Clin Oncol 28 464 471 16199985 10.1097/01.coc.0000180389.86104.68 1:CAS:528:DC%2BD2MXhtFKjur3P
17. Y Jiang YQ Wei F Luo, et al. 2005 Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study Cancer Invest 23 123 128 15813504
18. TK Yau AW Lee DH Wong, et al. 2006 Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma Head Neck 28 880 887 16721741 10.1002/hed.20421
19. TK Yau AW Lee DH Wong, et al. 2006 Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes Int J Radiat Biol Phys 66 4 1004 1010 10.1016/j.ijrobp.2006.06.016 1:STN:280:DC%2BD28jgvVCjsg%3D%3D
20. Y Fan NM Lin SL Ma, et al. 2010 Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer Acta Pharmacol Sin 31 746 752 20523345 10.1038/aps.2010.50 1:CAS:528:DC%2BC3cXmvFSqsLg%3D
21. M Squadroni N Fazio 2010 Chemotherapy in pancreatic adenocarcinoma Eur Rev Med Pharmacol Sci 14 386 394 20496553 1:STN:280:DC%2BC3czlvVGksA%3D%3D
22. DA Yardley NW Peacock NR Dickson 2010 A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer Clin Breast Cancer 10 217 223 20497920 10.3816/CBC.2010.n.029 1:CAS:528:DC%2BC3cXosVSmsro%3D
23. SM Ibrahim ZM Abd El-Hafeez EM Mohamed, et al. 2007 Transurethral resection of bladder tumor (TUR-BT) then concomitant radiation and cisplatin followed by adjuvant gemcitabine and cisplatin in muscle invasive transitional cell carcinoma (TCC) of the urinary bladder J Egypt Natl Cancer Inst 19 77 86
24. AK Verma AK Arya M Kumar, et al. 2009 Weekly cisplatin or gemcitabine concomitant with radiation in the management of locally advanced carcinoma cervix: result from an observational study J Gynecol Oncol 20 221 226 20041098 10.3802/jgo.2009.20.4.221 1:CAS:528:DC%2BC3MXhtlOntLjF
25. JL Wang XN Hong WY Tang, et al. 2005 Experience of gemcitabine plus cisplatin chemotherapy in 52 patients with head and neck cancer Zhonghua Zhong Liu Za Zhi 27 567 569 16438860 1:CAS:528:DC%2BD1cXhvFWn
26. PM Specenier J Weyler C Van Laer, et al. 2009 A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck BMC Cancer 9 273 19660134 10.1186/1471-2407-9-273